Stuart A Lipton MD PhD
Professor and Founding Director, Neurodegeneration New Medicines Center, Step Family Foundation Endowed Chair, Scripps Research; Professor of Neurology/Neurosciences (adj), UC San Diego School of Medicine & Yale School of Medicine. Previously: Asst., Assoc, Prof., Department of Neurology, Harvard Medical School; Director, CNS Research Institute, Brigham and Women's Hospital, Boston, Massachusetts
Join to view full profile
4510 Executive DrSte 325San Diego, CA 92121
Phone+1 858-657-8540
Dr. Lipton is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1978 - 1981
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1977 - 1978
Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
CA State Medical License 1999 - 2027
MA State Medical License 1981 - 2027
ME State Medical License Active through 1988
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
Publications & Presentations
PubMed
- Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer's disease brain.Lauren N Carnevale, Piu Banerjee, Xu Zhang, Jazmin Navarro, Charlene K Raspur
Cell Chemical Biology. 2026-08-20 - 1 citationsProteome-wide profiling of S-nitrosylated proteins using the SNOTRAP probe and mass spectrometry-based detection.Hongmei Yang, Haitham Amal, Steven R Tannenbaum, Stuart A Lipton
Nature Protocols. 2026-06-01 - Molecular and Structural Characterization Reveals Divergent Extracellular Vesicle Profiles Between Wild Type and Alzheimer's Disease Cerebrocortical Organoids.Anthony Balistreri, Natalie Turner, Jadon Compher, Mireya Almaraz, Akhil Prabhavalkar
Biorxiv. 2026-05-14
Press Mentions
Why Some People with down Syndrome Avoid Dementia Despite Alzheimer’s PathologyMarch 2nd, 2025- SNO-Y Protein Levels Help Explain Why More Women Develop Alzheimer’sJanuary 6th, 2023
- Beer, Dolphins and More Discoveries That Could Shed Light on Alzheimer’s DiseaseDecember 22nd, 2022
Grant Support
- Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRDSCRIPPS RESEARCH INSTITUTE, THE2024–2029
- Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's diseaseSCRIPPS RESEARCH INSTITUTE, THE2022–2027
- Leadership in AD/ADRD Drug DiscoverySCRIPPS RESEARCH INSTITUTE, THE2021–2026
- Project II - Clinically-Safe Nmdar Antagonists Prevent NeurotoxicityEunice Kennedy Shriver National Institute Of Child Health &Human Development2012
- Core A - Administrative And Statistical ComponentsEunice Kennedy Shriver National Institute Of Child Health &Human Development2012
Other Languages
- Spanish
Industry Relationships
- Scientific Advisory Board Member, Eli LillyMember of Neuroscience SABDisclosure: Consultancy payment2015 - Present
- Scientific Founder, ADAMAS Pharmaceuticals, Inc.Scientific Co-FounderDisclosure: Equity2000 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
